The unusual suspects: A surprise regarding reactions to omalizumab

Allergy and Asthma Proceedings

Volumn 28, Issue 3, 2007, Pages 259-261

  Lieberman, Phil ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; OMALIZUMAB; POLYSORBATE;

ANAPHYLAXIS; CHEMICALLY INDUCED DISORDER; DRUG HYPERSENSITIVITY; HUMAN; NOTE;

ANAPHYLAXIS; ANTIBODIES, MONOCLONAL; DRUG HYPERSENSITIVITY; HUMANS; POLYSORBATES;

EID: 34447279938     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/108854107781285717     Document Type: Note

References (12)

1. Schulman ES. Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders. Am J Respir Crit Care Med 164:S6-11, 2001.
2. Price KS, and Hamilton RG. Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy. Allergy Asthma Proc 28:313-319, 2007.
3. Chipps B. Systemic reaction to omalizumab. Ann Allergy Asth Immunol 97:267, 2006
4. Varghese M, and Lieberman P. The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin test to mouse antigen. Allergy Asthma Proc 28:320-323, 2007
5. Limaye S, Steele RH, Quin J, and Cleland B. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity. J Allergy Clin Immunol 110:530, 2002
6. Coors EA, Seybold H, Merk H, and Mahler B. Polysorbate 80 in medical products in non-immunologic anaphylactoid reactions. Ann Allergy Asth Immunol 95:593-599, 2005.
7. Szebeni J. Complement activation-related pseudoallergy. A new class of drug-induced acute immune toxicity. Toxicology 216: 106-121, 2005.
8. Rowinsky EK, Cazenave LA, and Donehower RC. Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247-1259, 1990.
9. Ennis M, Lorenz W, and Gerland W. Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor EL (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions? Agents Actions 18:235-238, 1986.
10. Fisherman EW, and Cohen GN. Tween 80 exacerbated intrinsic rhinitis and asthma in non-aspirin sensitive patients. Ann Allergy 32:307-320, 1974.
11. Toman M, Krejci J, Pinka K, and Mensik P. Causes of anaphylactoid reactions in cattle after administration of lipoid preparations. Vet Med (Praha) 37:417-426, 1992.
12. ten Tije AJ, Verweij J, Loos WJ, and Sparreboom A. Pharmacologic effects of formulation vehicles: Implications for cancer chemotherapy. Clin Pharmacokinetics 42:665-685, 2003.